Literature DB >> 935802

The disease activity of ulcerative colitis and Crohn's disease.

I Talstad, E Gjone.   

Abstract

The disease activity in ulcerative colitis and Crohn's disease was studied. Parameters found to reflect the disease activity were given scores from 1 to 4. The score obtained by a patient compared with the maximum scores gives the percentage disease activity. The regressions between the percentage disease activity and the ESR in ulcerative colitis and Crohn's disease were r=0.68 (p less than 0.001) and r=0.48 (p less than 0.001), respectively. The different activity parameters have different time response curves explaining the occasional slight correlation. The percentage disease activity represents the mean activity of the different parameters at a given time. It is proposed to define slight, moderate, and severe ulcerative colitis or Crohn's disease as percentage disease activity of less than 30, 30-70 and greater than 70 per cent, respectively.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 935802

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  23 in total

Review 1.  Evaluation of inflammatory activity in Crohn's disease and ulcerative colitis.

Authors:  Eduardo Garcia Vilela; Henrique Osvaldo da Gama Torres; Fabiana Paiva Martins; Maria de Lourdes de Abreu Ferrari; Marcella Menezes Andrade; Aloísio Sales da Cunha
Journal:  World J Gastroenterol       Date:  2012-03-07       Impact factor: 5.742

2.  DNA aneuploidy in Crohn's disease and ulcerative colitis: results of a comparative flow cytometric study.

Authors:  R Porschen; U Robin; A Schumacher; S Schauseil; F Borchard; K J Hengels; G Strohmeyer
Journal:  Gut       Date:  1992-05       Impact factor: 23.059

3.  Anti-neutrophil cytoplasmic antibodies (ANCA) in sera from patients with inflammatory bowel disease (IBD). Relation to disease pattern and disease activity.

Authors:  J Broekroelofs; A H Mulder; G F Nelis; B D Westerveld; J W Tervaert; C G Kallenberg
Journal:  Dig Dis Sci       Date:  1994-03       Impact factor: 3.199

4.  Activation of plasma contact and coagulation systems and neutrophils in the active phase of ulcerative colitis.

Authors:  A Stadnicki; M Gonciarz; T J Niewiarowski; J Hartleb; M Rudnicki; N B Merrell; R A Dela Cadena; R W Colman
Journal:  Dig Dis Sci       Date:  1997-11       Impact factor: 3.199

5.  The immediate and long-term effects of postoperative total parenteral nutrition on body composition.

Authors:  S Fasth; L Hultén; O Magnusson; S Nordgren; I Warnold
Journal:  Int J Colorectal Dis       Date:  1987-08       Impact factor: 2.571

6.  Hyposplenism in inflammatory bowel disease.

Authors:  B S Rameh; F M Stevens; C F McCarthy
Journal:  Ir J Med Sci       Date:  1988-01       Impact factor: 1.568

7.  A prospective study of the course of Crohn's disease.

Authors:  S Kaufman; B Chalmer; R Heilman; W Beeken
Journal:  Dig Dis Sci       Date:  1979-04       Impact factor: 3.199

Review 8.  Laboratory assessment of inflammatory bowel disease.

Authors:  I T Beck
Journal:  Dig Dis Sci       Date:  1987-12       Impact factor: 3.199

9.  Clinical impact of colectomy and ileorectal anastomosis in the management of Crohn's disease.

Authors:  N S Ambrose; M R Keighley; J Alexander-Williams; R N Allan
Journal:  Gut       Date:  1984-03       Impact factor: 23.059

10.  Controlled therapeutic trial of levamisole and sulphasalazine in acute ulcerative colitis.

Authors:  A Hermanowicz; A Nowak; L Gajos
Journal:  Gut       Date:  1984-05       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.